Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials

September 2018 | Volume 17 | Issue 9 | Original Article | 987 | Copyright © September 2018

Angela Moore MD,^a Lawrence J. Green MD,^b Suzanne Bruce MD,^c Neil Sadick MD,^d Eduardo Tschen MD MBA,^e Philip Werschler MD FAAD FAACS,^f Fran E. Cook-Bolden, MD,^g Sunil S. Dhawan MD,^h Douglass Forsha MD,ⁱ Michael H. Gold MD FAAD,^j Scott Guenthner MD,^k Steven E. Kempers MD,^l Leon H. Kircik MD,^m Jennifer L. Parish MD,ⁿ Marta I. Rendon MD,^o Phoebe Rich MD,^p Linda Stein-Gold MD,^q Stephen K. Tyring MD PhD,^r Robert A. Weiss MD FAAD,^s Adnan Nasir MD,^t Carsten Schmitz MD PhD,^u* Terry I. Boodhoo MS,^u Alexandre Kaoukhov MD,^u,* and David R. Berk MD^u

^aArlington Research Center, Inc., Arlington, TX ^bLawrence J. Green, MD, LLC, George Washington University School of Medicine, Washington, DC ^cSuzanne Bruce and Associates, PA, Houston, TX ^dSadick Research Group, New York, NY ^eAcademic Dermatology Associates, Albuquerque, NM ^fPremier Clinical Research, Spokane, WA ^gSkin Specialty Dermatology, New York, NY ^hCenter for Dermatology Clinical Research, Inc, Fremont, CA ⁱJordan Valley Dermatology Center, Jordan, UT ^jTennessee Clinical Research Center, Nashville, TN ^kThe Dermatology Center of Indiana, PC, Plainfield, IN ^lAssociated Skin Care Specialists, Fridley, MN ^mDermResearch, PLLC, Louisville, KY ⁿParish Dermatology, Philadelphia, PA ^oRendon Center, Boca Raton, FL ^pOregon Dermatology and Research Center, Portland, OR ^qHenry Ford Health System, West Bloomfield, MI ^rUniversity of Texas Health Science Center, Department of Dermatology, Houston, TX ^sLaser Skin & Vein Institute, Hunt Valley, MD ^tWake Research Associates, Raleigh, NC ^uAllergan plc, Irvine, CA *Former employee